Initial prognostic factors in small-cell lung Cancer patients predicting quality of life during chemotherapy

British Journal of Cancer

Volumn 74, Issue 10, 1996, Pages 1660-1667

  Bernhard, J ^a,j   Hurny C ^b   Bacchi, M ^a   Joss, R A ^c   Cavalli, F ^d   Senn, H J ^e   Leyvraz, S ^f   Stahel, R ^g   Ludwig, C ^h   Alberto, P ⁱ  

^a SIAK Coordinating Center   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c LUZERNER KANTONSSPITAL   (Switzerland)

^d OSPEDALE SAN GIOVANNI   (Switzerland)

^e Kantonsspital St Gallen Division of Oncology Haematology   (Switzerland)

^f LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^g UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^h UNIVERSITY HOSPITAL BASEL   (Switzerland)

ⁱ GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^j SIAK Coordinating Center   (Switzerland)

more..

Author keywords

Biomedical prognostic factors; Psychosocial adjustment; Quality of life; Small cell lung cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; LOMUSTINE; METHOTREXATE; VINCRISTINE SULFATE;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMOTION; FATIGUE; FEMALE; GENDER; HUMAN; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALAISE; MALE; MEDICAL DECISION MAKING; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; WEIGHT REDUCTION; WELLBEING;

EID: 10544228525     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.606     Document Type: Article

References (28)

1. AARONSON NK, BAKKER W, STEWART AL, VAN DAM FSAM, VAN ZANDWIJK N, YARNOLD JR AND KIRKPATRICK A. (1987). Multidimensional approach to the measurement of quality of life in lung cancer clinical trials. In The Quality of Life of Cancer Patients, Aaronson NK and Beckmann J. (eds) pp. 101-109. Raven Press: New York.
2. BERGMAN B AND AARONSON NK. (1995). Quality-of-life and cost-effectiveness assessment in lung cancer. Curr. Opin. Oncol., 7, 138-143.
3. BERNHARD J. (1992). 'Lebensqualität' in Onkologischen Therapie-studien. Konzepte, Methodik und Anwendung am Beispiel des Kleinzelligen Bronchuskarzinoms. Peter Lang: Bern.
4. BERNHARD J AND GANZ PA. (1995). Psychosocial issues in lung cancer patients. Cancer Treat. Res., 72, 363-390.
5. BLANCHARD CG, LABRECQUE MS, RUCKDESCHEL JC AND BLANCHARD EB. (1988). Information and decision-making preferences of hospitalized adult cancer patients. Soc. Sci. Med., 27, 1139-1145.
6. BLEEHEN NM, FAVERS PM, GIRLING DJ AND STEPHENS RJ. (1989). Survival, adverse reactions and quality of life during combination chemotherapy compared with selective treatment for small cell lung cancer. Resp. Med., 83, 51-58.
7. BLEEHEN NM, GIRLING DJ, MACHIN D AND STEPHENS RJ. (1993). A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Party. Br. J. Cancer, 68, 1157-1166.
8. CELLA DF, OROFIAMMA B, HOLLAND JC, SILBERFARB PM, TROSS S, FELDSTEIN M, PERRY M, MAURER LH, COMIS R AND ORAV EJ. (1987). The relationship of psychosocial distress, extent of disease, and performance status in patients with lung cancer. Cancer. 60, 1661-1667.
9. COATES A, GEBSKI V, BISHOP JF, JEAL PN, WOODS RL, SNYDER R, TATTERSALL MHN, BYRNE M, HARVEY V, GILL G, SIMPSON J, DRUMMOND R, BROWNE J, VAN COOTEN R AND FORBES JF FOR THE AUSTRALIAN NEW ZEALAND BREAST CANCER TRIALS GROUP. (1987). Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies N. Engl. J. Med., 317, 1490-1495.
10. DAVIS CS. (1991). Semi-parametric and non-parametric methods for the analysis of repeated measurements with applications to clinical trials. Stats. Med., 10, 1959-1980.
11. EARL HM, RUDD RM, SPIRO SG, ASH CM, JAMES LE, LAW CS, TOBIAS JS, HARPER PG, GEDDES DM, ERAUT D, PARTRIDGE MR AND SOUHAMI RL. (1991). A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trial. Br. J. Cancer, 64, 566-572.
12. EORTC QUALITY OF LIFE STUDY GROUP. (1995). EORTC QLQ-C30 Scoring Manual. EORTC Data Center: Brussels.
13. FLETCHER A, GORE S, JONES D, KITZPATRICK R, SPIEGELHALTER D AND COX D. (1992). Quality of life measures in health care. II. Design, analysis and interpretation. Br. Med. J., 305, 1145-1148.
14. GANZ PA, SCHAG CAC, LEE JJ AND SIM MS. (1992). The CARES: a generic measure of health-related quality of life for patients with cancer. Qual. Life Res., 1, 19-29.
15. GOWER NH, RUDD RM, DE ELVIRA MCR, SPIRO SG, JAMES LE, HARPER PG AND SOUHAMI RL. (1995). Assessment of 'quality of life' using a daily diary card in a randomised trial of chemotherapy in small-cell lung cancer. Ann. Oncol., 6, 575-580.
16. HOPWOOD P AND THATCHER N. (1990). Preliminary experience with quality of life evaluation in patients with lung cancer. Oncology, 4, 158-162.
17. HOPWOOD P, STEPHENS RJ AND MACHIN D. (1994). Approaches to the analysis of quality of life data: experiences gained from a medical research council lung cancer working party palliative chemotherapy trial. Qual. Life Ras., 3, 339-352.
18. HÜRNY C, BERNHARD J, JOSS R, WILLEMS Y, CAVALLI F, KISER J, BRUNNER K, FAVRE S, ALBERTO P, GLAUS A, SENN HJ, SCHATZMANN E, GANZ PA AND METZGER U FOR THE SWISS GROUP FOR CLINICAL CANCER RESEARCH (SAKK). (1992). Feasibility of quality of life assessment in a randomized phase III trial of small cell lung cancer a lesson from the real world. Ann. Oncol., 3, 825-831.
19. JOSS RA, ALBERTO P, HÜRNY C, BACCHI M, LEYVRAZ S, THÜRLIMANN B, CERNY T, MARTINELLI G, STAHEL R AND LUDWIG C FOR THE SWISS GROUP FOR CLINICAL CANCER RESEARCH (SAKK). (1995a). Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A randomised phase III comparison of weekly carboplatin and teniposide versus cisplatin, adriamycin, etoposide alternating with cyclophosphamide, methotrexate, vincristine and lomustine. Ann. Oncol., 6, 41-48.
20. JOSS RA, BACCHI M, HÜRNY C, BERNHARD J, CERNY T, MARTINELLI G, LEYVRAZ S, SENN HJ, STAHEL R, SIEGENTHALER P, LUDWIG C AND ALBERTO P FOR THE SWISS GROUP FOR CLINICAL CANCER RESEARCH (SAKK). (1995b). Early versus late alternating chemotherapy in small-cell lung cancer. Ann. Oncol., 6, 157-166.
21. MATTHEWS JNS. (1993). A refinement to the analysis of serial data using summary measures. Stat. Med., 12, 27-37.
22. MCNAIR DM, LORR M AND DROPPLEMAN LF. (1971). EITS manual for the profile of mood states. Educational and Industrial Testing Service: San Diego.
23. NETER J, WASSERMAN W AND KUTNER MH. (1985). Applied linear statistical models. Regression, analysis of variance, and experimental designs. Irwin: Illinois.
24. SIEGEL S. (1956). Nonparametric statistics for the Behavioral Sciences. McGraw-Hill: New York.
25. TANDON PK. (1990). Application of global statistics in analyzing quality of life data. Stat. Med., 9, 819-827.
26. VON ZERSSEN D. (1986). Clinical self-rating scales (CSRS) of the Munich Psychiatric Information System (PSYCHIS München). In Assessment of Depression, Sartorius N and Ban TA. (eds) pp. 270-303. Springer: Berlin.
27. WOLF M, PRITSCH M, DRINGS P, HANS K, SCHROEDER M, FLECHTNER H, HEIM M, HRUSKA D, MENDE S, BECKER H, DANNHÄUSER J, LOHMÜLLER R, GROPP C, GASSEL WD, HOLLE RAND HAVEMANN K. (1991). Cyclic-alternating versus response-oriented chemotherapy in small-cell lung cancer: a German multicenter randomized trial of 321 patients. J. Clin. Oncol., 9, 614-624.
28. WORLD HEALTH ORGANIZATION. (1979). WHO Handbook for Reporting Results of Cancer Treatment. WHO Offset Publication No. 48: Geneva.